SEBI

Finance

19 September, 2022

Sebi puts Fairfax-backed Go Digit's IPO in "abeyance"

Capital markets regulator Sebi has kept in “abeyance” the proposed initial public offering (IPO) of Go Digit General Insurance Ltd, ......

Premium

Finance

19 September, 2022

C4D Partners gets Sebi nod for debut $50 million India fund

Dutch impact investor Capital 4 Development Partners BV (C4D Partners) has received approval from the Securities and Exchange Board of ......

Premium

TMT

14 September, 2022

Bunch of new companies set to electrify the IPO pool again

Encouraged by Indian stocks’ outperformance of emerging market peers, a bunch of relatively large companies is set to test investors’ ......

Premium

Finance

14 September, 2022

20 private funds managing ₹10,000 cr under Sebi lens

The Securities Exchange Board of India (Sebi) is probing practices adopted by at least 20 Indian-domiciled alternative investment funds (AIFs) ......

Finance

13 September, 2022

Sebi has no role in IPO pricing: chairperson

Securities and Exchange Board of India (Sebi) chairperson Madhabi Puri Buch on Tuesday said the regulator does not have any ......

Healthcare

02 September, 2022

Toro gets SEBI nod to expand healthcare fund

Private equity firm Toro Finserve LLP, has got Sebi’s nod to expand its existing $500 million fund to $900 million ......

General

29 August, 2022

Adani, NDTV promoters move SEBI on warrant conversion

Promoter of New Delhi Television Ltd (NDTV), RRPR Holding Ltd and Adani group have approached the markets regulator, Securities and ......

Finance

21 August, 2022

PharmEasy's parent firm withdraws IPO papers, plans to raise funds via rights issue

PharmEasy’s parent company, API Holdings Ltd, has withdrawn the draft red herring prospectus (DRHP) it filed with the Securities and ......

Finance

18 August, 2022

SEBI waives need for ‘Indian connect' for VC/PE funds' overseas investments

The Securities Exchange Board of India (SEBI) has relaxed two norms governing overseas investments of Indian private equity and venture ......

Healthcare

17 August, 2022

Rakesh Jhunjhunwala firm-backed Concord Biotech files for IPO

Late billionaire investor Rakesh Jhunjhunwala's firm Rare Enterprises-backed Concord Biotech has filed its draft red herring prospectus (DRHP) with capital ......